PRQR logo

ProQR Therapeutics NV (PRQR) Current Liabilities

Annual Current Liabilities

$37.81 M
+$15.30 M+67.98%

31 December 2023

PRQR Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Liabilities

$44.27 M
+$4.31 M+10.80%

01 September 2024

PRQR Quarterly Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PRQR Current Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+68.0%+57.0%
3 y3 years+198.4%+10.0%
5 y5 years+305.1%+263.4%

PRQR Current Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+198.4%at high+136.6%
5 y5 yearsat high+305.1%at high+338.6%
alltimeall timeat high>+9999.0%at high+1272.8%

ProQR Therapeutics NV Current Liabilities History

DateAnnualQuarterly
Sept 2024
-
$44.27 M(+10.8%)
June 2024
-
$39.96 M(+7.5%)
Mar 2024
-
$37.17 M(-1.7%)
Dec 2023
$37.81 M(+68.0%)
$37.81 M(+34.0%)
Sept 2023
-
$28.21 M(+13.0%)
June 2023
-
$24.97 M(+33.4%)
Mar 2023
-
$18.71 M(-16.9%)
Dec 2022
$22.51 M(-28.0%)
$22.51 M(-15.1%)
Sept 2022
-
$26.51 M(-6.5%)
June 2022
-
$28.35 M(+7.1%)
Mar 2022
-
$26.47 M(-15.3%)
Dec 2021
$31.24 M(+146.6%)
$31.24 M(-22.3%)
Sept 2021
-
$40.23 M(+173.2%)
June 2021
-
$14.73 M(+19.7%)
Mar 2021
-
$12.30 M(-2.9%)
Dec 2020
$12.67 M(+2.9%)
$12.67 M(-0.2%)
Sept 2020
-
$12.70 M(+25.0%)
June 2020
-
$10.16 M(+0.6%)
Mar 2020
-
$10.10 M(-18.0%)
Dec 2019
$12.31 M
$12.31 M(+1.1%)
Sept 2019
-
$12.18 M(+18.4%)
June 2019
-
$10.29 M(-5.5%)
DateAnnualQuarterly
Mar 2019
-
$10.89 M(+16.6%)
Dec 2018
$9.33 M(-8.4%)
$9.33 M(-21.7%)
Sept 2018
-
$11.93 M(+17.4%)
June 2018
-
$10.16 M(+16.3%)
Mar 2018
-
$8.74 M(-14.3%)
Dec 2017
$10.19 M(+43.7%)
$10.19 M(+35.7%)
Sept 2017
-
$7.51 M(+18.9%)
June 2017
-
$6.31 M(-9.8%)
Mar 2017
-
$7.00 M(-1.3%)
Dec 2016
$7.09 M(+18.3%)
$7.09 M(-18.5%)
Sept 2016
-
$8.71 M(+1.2%)
June 2016
-
$8.60 M(+25.3%)
Mar 2016
-
$6.87 M(+14.5%)
Dec 2015
$6.00 M(+63.6%)
$6.00 M(+10.8%)
Sept 2015
-
$5.42 M(-6.4%)
June 2015
-
$5.79 M(+12.2%)
Mar 2015
-
$5.16 M(+40.8%)
Dec 2014
$3.67 M(-26.3%)
$3.67 M(+9.7%)
Sept 2014
-
$3.34 M(+3.6%)
June 2014
-
$3.23 M(-35.2%)
Dec 2013
$4.97 M(+2530.3%)
$4.97 M
Dec 2012
$189.10 K
-

FAQ

  • What is ProQR Therapeutics NV annual total current liabilities?
  • What is the all time high annual current liabilities for ProQR Therapeutics NV?
  • What is ProQR Therapeutics NV annual current liabilities year-on-year change?
  • What is ProQR Therapeutics NV quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for ProQR Therapeutics NV?
  • What is ProQR Therapeutics NV quarterly current liabilities year-on-year change?

What is ProQR Therapeutics NV annual total current liabilities?

The current annual current liabilities of PRQR is $37.81 M

What is the all time high annual current liabilities for ProQR Therapeutics NV?

ProQR Therapeutics NV all-time high annual total current liabilities is $37.81 M

What is ProQR Therapeutics NV annual current liabilities year-on-year change?

Over the past year, PRQR annual total current liabilities has changed by +$15.30 M (+67.98%)

What is ProQR Therapeutics NV quarterly total current liabilities?

The current quarterly current liabilities of PRQR is $44.27 M

What is the all time high quarterly current liabilities for ProQR Therapeutics NV?

ProQR Therapeutics NV all-time high quarterly total current liabilities is $44.27 M

What is ProQR Therapeutics NV quarterly current liabilities year-on-year change?

Over the past year, PRQR quarterly total current liabilities has changed by +$16.07 M (+56.96%)